Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy

M. Smith-Uffen, J. Park, A. Parsonson, A. Vasista

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	438P
Pages (from-to)	S1611
Number of pages	1
Journal	Annals of Oncology
Volume	33
Issue number	Supplement 9
DOIs	https://doi.org/10.1016/j.annonc.2022.10.469
Publication status	Published - Nov 2022
Externally published	Yes
Event	European Society for Medical Oncology (ESMO) Asia Congress 2022 - Singapore, Singapore Duration: 2 Dec 2022 → 4 Dec 2022

Access to Document

@article{3e0627383a764286a4797181966c02d5,

title = "Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy",

author = "M. Smith-Uffen and J. Park and A. Parsonson and A. Vasista",

year = "2022",

month = nov,

doi = "10.1016/j.annonc.2022.10.469",

language = "English",

volume = "33",

pages = "S1611",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "OXFORD UNIV PRESS INC",

number = "Supplement 9",

note = "European Society for Medical Oncology (ESMO) Asia Congress 2022 ; Conference date: 02-12-2022 Through 04-12-2022",

}

TY - JOUR

T1 - Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy

AU - Smith-Uffen, M.

AU - Park, J.

AU - Parsonson, A.

AU - Vasista, A.

PY - 2022/11

Y1 - 2022/11

U2 - 10.1016/j.annonc.2022.10.469

DO - 10.1016/j.annonc.2022.10.469

M3 - Meeting abstract

SN - 0923-7534

VL - 33

SP - S1611

JO - Annals of Oncology

JF - Annals of Oncology

IS - Supplement 9

M1 - 438P

T2 - European Society for Medical Oncology (ESMO) Asia Congress 2022

Y2 - 2 December 2022 through 4 December 2022

ER -